58
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39516 |
Bocidelpar
|
PPAR | DNA Damage/DNA Repair; Metabolism |
Bocidelpar 是一种有效的过氧化物酶体增殖物激活受体 delta 调节剂,可改善杜兴肌营养不良肌肉细胞中的线粒体生物合成和功能。 | |||
T7837 |
SR8278
|
Others | Others |
SR8278 是竞争性核血红素受体REV-ERB 合成拮抗剂,能够抑制 REV-ERBα 转录活性(EC50:0.47 μM)。它可用于调节生物体内的代谢和研究生物节律。 | |||
T16545 |
Pivanex
Pivalyloxymethyl butyrate,AN-9 |
Apoptosis; HDAC; Bcr-Abl | Angiogenesis; Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; Tyrosine Kinase/Adaptors |
Pivanex (Pivalyloxymethyl butyrate) 是丁酸的一种衍生物,是具有口服活性的 HDAC 抑制剂。Pivanex 通过下调 bcr-abl 蛋白增强凋亡。Pivanex 显示出抗转移和抗血管生成的活性。 | |||
T17217 |
Vamorolone
地塞米松EP杂质E,VBP15 |
Glucocorticoid Receptor; NF-κB | Endocrinology/Hormones; NF-κB |
Vamorolone (VBP15) 是一种首创的,具有口服活性的解离性类固醇 (dissociative steroidal) 抗炎药和膜稳定剂。它抑制 (NF-κB) 抑制作用,并降低了激素的影响。它改善肌营养不良,无副作用。 | |||
T4641 |
Branaplam
LMI 070,NVS-SM1 |
Others; Potassium Channel; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Membrane transporter/Ion channel; Others |
Branaplam (LMI 070) 是一种高效、选择性和口服活性的小分子 SMN2 剪接调节剂,对 SMN 的 EC50为 20 nM。它可提高全长 SMN 蛋白并延长其生存期,也抑制 hERG,IC50为 6.3 μM。 | |||
T3424 |
Ezutromid
BMN 195,VOX-C1100,依珠曲米,SMT C1100 |
Others | Others |
Ezutromid (BMN 195) 是一种具有口服活性的、首创的苯并恶唑 utrophin 调节剂,EC50=0.91 μM。它抑制人肝微粒体 CYP1A2 酶活性,IC50=5.4 μM。它可用于 Duchenne 型肌营养不良症 (DMD) 的研究。 | |||
T13491 |
Neuromuscular-targeting compound 1
|
Others | Others |
Neuromuscular-targeting compound 1 可用于研究肌肉萎缩和神经肌肉相关疾病。 | |||
T10059 |
Neuromuscular Disorder-Targeting Compound 1
|
Others | Others |
Neuromuscular Disorder-Targeting Compound 1 is a compound used in the research of neuromuscular disorders, for example, symptoms of chronic fatigue syndrome and fibromyalgia syndrome. | |||
T12718L |
RG7800
RO6885247 |
Others; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Others |
RG7800 (RO6885247) 是一种 SMN2 拼接修饰剂,有用于治疗脊髓性肌萎缩的研究潜力。 | |||
T7722 |
Feprazone
Prenazone,非普拉宗,DA 2370,DA2370,DA-2370 |
Others | Others |
Feprazone (DA-2370) 具有抗炎和抗脂肪生成特性。 Feprazone 可用于治疗关节和肌肉疼痛的研究。 | |||
T3336 |
Rg3039
PF-06687859 |
Others | Others |
Rg3039 (PF-06687859) 是一种具有口服活性、能够透过血脑屏障的DcpS 抑制剂,其IC50=0.069 nM。 | |||
T77445 |
Apitegromab
SRK-015 |
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
Apitegromab (SRK-015) 是一种新型肌肉生长抑制素抑制剂,是一种靶向肌肉生长抑制素前体的抗体,可用于研究脊髓性肌萎缩症在内的神经肌肉疾病。 | |||
T12935 |
SMN-C3
MV8T2MCK57 |
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
SMN-C3 (MV8T2MCK57) 是口服有效的 SMN2 剪接调节剂。SMN-C3可用于脊椎肌肉萎缩 (SMA) 的研究。 | |||
T0319 |
Suxibuzone
琥布宗,Calibene,Suxibuzonum,Suxibuzona |
COX | Immunology/Inflammation; Neuroscience |
Suxibuzone (Suxibuzona) 是非甾体类抗炎药 Phenylbutazone 的前药,可用于关节和肌肉疼痛研究。 | |||
T1805 |
Ataluren
PTC124 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
Ataluren (PTC124) 是一种可口服的 CFTR-G542X 无义等位基因抑制剂。 | |||
T73475 |
SMN-C2
|
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
SMN-C2 是一种选择性的 SMN2 基因剪接调节剂,是risdiplam类似物,是调节前 mRNA 剪接的选择性 RNA 结合配体,通过结合 SMN2 pre-mRNA 来发挥作用。SMN-C2 具有研究脊髓性肌萎缩症 (SMA) 的潜力。 | |||
T9821 |
ART-CHEM-BB B025267
2-(4-二乙基氨基苯基)-6-甲基-5-苯并三唑胺 |
Others | Others |
ART-CHEM-BB B025267 是 utrophin 生成的上调剂,EC50 为 1.8 μM,可用于治疗 Duchenne 肌营养不良症的研究。 | |||
T2553 |
Etofenamate
|
COX | Immunology/Inflammation; Neuroscience |
Etofenamate 是非甾体类抗炎小分子,也是非选择性的 COX 抑制剂,具有抗风湿和解热抗炎作用,可用于缓解疼痛、关节炎等炎症相关疾病的研究。 | |||
T72073 |
AKOS037652256
|
||
AKOS037652256可作为 TRPML 调节剂,可用于治疗如溶酶体积存病、肌肉萎缩症、与年龄相关的常见神经退行性疾病、氧化应激或活性氧(ROS)相关疾病以及衰老等与 TRPML 活性相关的疾病。 | |||
T0511 |
Tolperisone hydrochloride
盐酸托哌酮,Muscalm,Midocalm,托哌酮盐酸盐,Tolperisone HCl |
Sodium Channel | Membrane transporter/Ion channel |
Tolperisone hydrochloride (Muscalm) 是中枢作用肌肉松弛剂,可用于研究神经疾病引起的病理性横纹肌硬化(锥体束损伤、脊髓病、多发性硬化症、脑脊髓炎)、痉挛性麻痹及其他肌肉张力障碍相关的脑病。 | |||
T72072 |
2-benzylsulfanyl-6-methoxy-4-methylquinazoline
|
ROS | Immunology/Inflammation |
2-benzylsulfanyl-6-methoxy-4-methylquinazoline 可作为TRPML 调节剂,可用于治疗与TRPML 活性相关的疾病,如溶酶体储存病、肌肉萎缩症、氧化应激或活性氧(ROS)相关疾病和衰老。 | |||
T15945 |
MA-0204
|
PPAR | DNA Damage/DNA Repair; Metabolism |
MA-0204 是一种高选择性,可口服的过氧化物酶体增殖物激活受体 δ (PPARδ) 调节剂,对于人,小鼠和大鼠 PPARδ 的 EC50分别为 0.4、7.9 和 10 nM。它有用于 Duchene 肌营养不良症 (DMD) 的研究潜力。 | |||
T21792 |
CGP 3466B maleate
马来酸CGP3466B,Omigapil (Maleate),Omigapil maleate |
Apoptosis | Apoptosis |
CGP 3466B maleate (Omigapil maleate) 是一种口服有效的 GAPDH 亚硝基化抑制剂,可消除 Aβ1-42 诱导的小鼠 tau 乙酰化,记忆障碍和运动功能障碍,Omigapil maleate 具有研究阿尔茨海默症的潜力。Omigapil maleate (CGP3446B maleate) 是一种有效的凋亡 (apoptosis) 抑制剂。Omigapil maleate 可用于研究先天性肌营养不良 (CMD)。 | |||
T22232 |
Alfuzosin
|
||
Alfuzosin 是选择性和竞争性的α1肾上腺素受体拮抗剂,可用于良性前列腺增生(BPH)的研究。 | |||
T31168 |
D153249
D 153249,D-153249 |
||
D153249 is a promoter of spinal muscular atrophy (SMA). | |||
T38554 |
Eteplirsen
依特立生;依特普森,AVI 4658 |
||
Eteplirsen (AVI 4658) is a synthetic antisense oligonucleotide utilized in research for Duchenne muscular dystrophy. | |||
T83175 |
Activated DPG Subunit
|
||
Activated DPG Subunit 用于合成可诱导外显子 51 跳跃的外显子跳跃寡聚物偶联物。这些偶联物与人抗肌萎缩蛋白基因中选定的靶位点互补,有助于肌肉萎缩症的研究。 | |||
T34425 |
RTC13
Read-through compound 13,RTC 13,RTC-13 |
||
RTC13, as a premature termination codon (PTC) readthrough inducer, can act by restoring dystrophin expression and improving muscle function in the mdx mouse model for Duchenne muscular dystrophy. | |||
T79918 |
α7β1 integrin modulator-1
|
Integrin | Cytoskeletal Signaling |
α7β1integrinmodulator-1,作为一种高效的α7β1integrin调节剂,展现出在肌营养不良症研究中的应用潜力。 | |||
T83177 | Activated A Subunit | ||
Activated A Subunit 适用于合成促进外显子跳跃的寡聚物偶联体。所合成的偶联体与人类抗肌萎缩蛋白基因内特定的序列配对互补,能够有效促进外显子51的跳跃,为肌萎缩疾病研究提供了一种工具。 | |||
T83176 | Activated C Subunit | ||
Activated C Subunit 用于合成可诱导外显子51跳跃的外显子跳跃寡聚物偶联物。所得寡聚物偶联物与人类抗肌萎缩蛋白基因特定靶位点互补,有助于研究肌肉萎缩症。 | |||
T83174 | Activated EG3 Tail | ||
Activated EG3 Tail 适用于合成外显子跳跃寡聚物偶联物。该寡聚物偶联物能与人类抗肌萎缩蛋白基因特定的靶位点匹配,进而诱导外显子 51 的跳跃。此类偶联物对于肌肉萎缩症研究具有重要价值。 | |||
T39517 |
Suvodirsen
WVE-210201 |
||
Suvodirsen (WVE-210201) is an oligonucleotide compound with potential applications in the study of Duchenne muscular dystrophy (DMD). | |||
T34426 |
RTC14
Read-through compound-14,RTC 14,RTC-14,Read-through compound 14 |
||
RTC14, as a premature termination codon (PTC) readthrough inducer, can act by restoring dystrophin expression and improving muscle function in the mdx mouse model for Duchenne muscular dystrophy. | |||
T7710L |
Mofebutazone sodium
BRN0213056,BRN 0213056,BRN-0213056 |
||
Mofebutazone sodium is, a nonsteroidal antiinflammatory drug (NSAID), is used to treat joint and muscular pain. | |||
T34664 |
SMN2-Stablizer-27
SMN2-Stablizer 27,SMN2 Stablizer-27 |
||
SMN2-Stablizer-27 is a stablizer of survival of motor neuron 2 (SMN2), and a post-translationally stablizing SMN protein for the treatment of spinal muscular atrophy (SMA). | |||
T83173 | Activated T Subunit | ||
Activated T Subunit 用于合成可诱导外显子51跳跃的外显子跳跃寡聚物偶联物。该寡聚物偶联物与人类抗肌萎缩蛋白基因中选定靶位点互补,适用于肌肉萎缩症研究。 | |||
T81693 |
NCP2 Anchor
|
||
NCP2 Anchor用于合成外显子跳跃寡聚物偶联物。它的偶联物与人抗肌萎缩蛋白基因特定靶位点配对互补,从而诱导外显子52的跳跃。该偶联物常应用于肌肉萎缩症的科学研究。 | |||
T60594 | OX01914 | ||
OX01914 是一种水溶性和细胞膜可渗透的 utrophin 调节剂,能够上调 utrophin 蛋白水平,EC50值为 20.5 μM。 OX01914 可用于研究杜氏肌肉营养不良症(DMD)。 | |||
T66481 |
TG-693
|
||
TG693, an orally available inhibitor of CLK1, promotes the skipping of the endogenous mutated exon 31 in Duchenne muscular dystrophy (DMD) patient-derived cells and increased the production of the functional exon 31-skipped dystrophin protein. | |||
T38860 |
Golodirsen
Golodirsen,SRP-4053 |
||
Golodirsen (SRP-4053) is a phosphorodiamidate morpholino oligomer (PMO) designed to selectively bind and target exon 53 of dystrophin pre-mRNA, with applications in the investigation of Duchenne muscular dystrophy (DMD). | |||
T33595 |
Naproxcinod
AZD3582,Nitronaproxen,AZD-3582,Naproxen-N-butyl nitrate,HCT3012,AZD 3582 |
||
Naproxcinod, a nitric oxide-releasing NSAID derivative, significantly improved skeletal muscle strength and fatigue resistance in sedentary and exercise mice, reducing inflammatory infiltration and fibrotic deposition in the myocardium and diaphragm. In a | |||
T39455 |
Viltolarsen
NS-065,NCNP-01 |
||
Viltolarsen (NS-065/NCNP-01) is a phosphorodiamidate morpholino antisense oligonucleotide that specifically targets the splicing of exon 53 in the dystrophin gene. It is utilized in research related to Duchenne muscular dystrophy (DMD). | |||
T14129 |
Adenylosuccinic acid
Aspartyl adenylate,Adenylosuccinate |
Others | Others |
Adenylosuccinic acid (Adenylosuccinate; Aspartyl adenylate) is a purine ribonucleoside monophosphate and plays a role in nucleotide cycle metabolite. Adenylosuccinic acid has the potential for the study of duchenne muscular dystrophy(DMD)[1] and can be co | |||
T82222 |
H-D-MeAla-EtVaI-VaI-MeLeu-AIa-D-AIa-MeLeu-MeLeu-MeVaI-MeBmt(OAc)-Abu-O-CH2-CH2-NHMe
|
||
H-D-MeAla-EtVal-Val-MeLeu-AIa-D-AIa-MeLeu-MeLeu-MeVal-MeBmt(OAc)-Abu-O-CH2-CH2-NHMe 是一种非免疫抑制性的环孢菌素A衍生物,具备研究先天性肌营养不良症潜力[1]。 | |||
T61645 |
Utrophin modulator 1
|
||
Utrophin Modulator 1 (UM1) is a highly effective agent that upregulates utrophin protein levels, displaying an EC 50 of 0.11 μM. Its application in the investigation of Duchenne Muscular Dystrophy (DMD) has been well-established [1]. | |||
T60261 | Clorprenaline | ||
Clorprenaline 是一种有效的β2-adrenergic 激动剂。Clorprenaline 促进动物肌肉生长并减少脂肪堆积。Clorprenaline 是一种潜在的新型瘦肉增效饲料添加剂。 | |||
T73321 |
CLK1-IN-2
|
||
CLK1-IN-2 是代谢稳定的Clk1抑制剂。CLK1-IN-2 对 Clk1 具有选择性,IC50值为 1.7 nM。CLK1-IN-2 可用于肿瘤、杜氏肌营养不良症和病毒感染如HIV-1和流感的研究。 | |||
T78046 |
RG7800 tetrahydrochloride
RO6885247 tetrahydrochloride |
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
RG7800 hydrochloride为一可口服SMN2剪接调节剂,其对SMN2剪接及SMN蛋白的EC1.5x值分别为23 nM及87 nM。 | |||
T82778 |
Cardioexcitatory peptide 1
|
||
Cardioexcitatory peptide 1为从非洲大蜗牛(Achatina)心房分离的心兴奋性神经肽。该化合物对心脏具有显著的兴奋效应,并能影响肌肉组织的运动及神经活动。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0399 |
Methyl salicylate
Gaultheria oil,Methyl 2-hydroxybenzoate,2-Carbomethoxyphenol,Betula oil,水杨酸甲酯,Natural wintergreen oil,Wintergreen oil |
COX; TRP/TRPV Channel | Immunology/Inflammation; Membrane transporter/Ion channel; Neuroscience |
Methyl salicylate (Gaultheria oil) 是从番泻叶中提取的一种天然三萜皂苷,是一种局部缓解疼痛和抗炎作用的药物。 它还用作食品和烟草制品中的农药、变性剂、香料成分和调味剂。 |